GNC reports 2008 financial results Economy's a beast for prestige beauty industry, research concludes Sun Pharmaceuticals subsidiary extends tender offer for Taro Endo subsidiary to acquire Indevus Proxy battle looms for Target Corp. as board rejects Pershing proposal CV Therapeutics' board of directors rejects Astellas' tender offer HHS launches new federal office to coordinate Recovery Act spending Via Pharmaceuticals secured note purchase agreement with Bay City Capital Fund Gilead Sciences to acquire CV Therapeutics Roche to acquire Genentech for $46.8 billion First Previous 296 297 298 299 300 Next Last
